Anupam Rasayan India has proposed purchasing a 26% share in Bliss GVS Pharma for approximately INR 829 crores, following an earlier deal for a 43.3% stake. This move, which values each share at INR 299, is subject to SEBI's Substantial Acquisition of Shares and Takeovers (SAST) regulations.

Bliss GVS Pharma has proposed a dividend of ₹1 for the fiscal year 2026, subject to approval at the AGM. The stock is currently trading at ₹272.85 on BSE, with an intraday high of ₹285.1 and a daily turnover of approximately ₹3.5 crore.

Bliss GVS Pharma reported a significant 129% year-on-year increase in Q4 FY26 net profit at Rs. 35.6 crore, accompanied by a 100% dividend announcement due to robust cash flows. The company's revenue also rose by 29.8% YoY to Rs. 257 crore, contributing to a 52-week high stock price of Rs. 285 and generating impressive 69% year-to-date returns.

Bliss GVS Pharma experienced a significant growth in their Q4 revenue, marking a 29.8% year-on-year increase to reach approximately 2.57 billion Indian Rupees.

Bliss GVS Pharma will convene a board meeting on May 12, 2026, for the approval of their audited financial results for the fiscal year ending March 31, 2026. This gathering will also involve discussions about potential dividend recommendations and a review of the company's financial statements.

Bliss GVS Pharma reaches an all-time high of Rs. 277.45 on April 23, 2026, indicating a robust performance within the Pharmaceuticals and Biotechnology sector.

Credit rating agency ICRA has assigned Bliss GVS Pharma an 'ICRA A (Stable)' long-term and 'ICRA A2' short-term rating for their ₹100 crore facilities, indicating a strong credit profile. The evaluation covers both fund-based and non-fund-based facilities, with a scheduled review within the year.

Analysts recommend investing in Kakatiya Cement, Bliss GVS Pharma, and Arvind as market volatility offers potential buy opportunities. Suggested price targets are Rs 105-120 for Kakatiyas, Rs 245 for Bliss GVS, and Rs 430 for Arvind. For risk management, it's advised to set stop-losses.